Roy Garcia
Impact in
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions
- HER2/EGFR in Cancer Research
-
- Cancer Mechanisms and Therapy
Papers in
- Oncology 17
- Cytokine Signaling Pathways and Interactions 16
-
- Cancer Mechanisms and Therapy 8
- Co-authors
- Richard JoveTammy BowmanJames TurksonRolf P. de GrootEric CaldenhovenCarlos Muro‐CachoRobert E. FalconeHua Yu
- Journals
- Oncogene (4 papers)Journal of Biomedical Science (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Blood (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSpainPortugal
In The Last Decade
Roy Garcia
28 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 3.3k
- Pathology and Forensic Medicine 988
- Cancer Research 780
- Immunology 1.1k
- Toxicology 172
Countries citing papers authored by Roy Garcia
This map shows the geographic impact of Roy Garcia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Garcia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Garcia more than expected).
Fields of papers citing papers by Roy Garcia
This network shows the impact of papers produced by Roy Garcia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Garcia. The network helps show where Roy Garcia may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Garcia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 11 | |
| 2 | 2007 | 1 | |
| 3 | 2006 | 205 | |
| 4 | 2005 | 49 | |
| 5 | 2005 | 9 | |
| 6 | 2003 | 43 | |
| 7 | 2002 | 12 | |
| 8 | 2001 | 156 | |
| 9 | 2001 | 1 | |
| 10 | STATs in oncogenesis Hit paper breakdown → | 2000 | 1530 |
| 11 | 2000 | 99 | |
| 12 | 1998 | 178 | |
| 13 | 1998 | 19 | |
| 14 | Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation Hit paper breakdown → | 1998 | 583 |
| 15 | 1997 | 171 | |
| 16 | Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. | 1997 | 328 |
| 17 | 1996 | 8 | |
| 18 | Molecular alterations during colon tumorigenesis: An overview of growth regulatory pathways and potential therapeutic implications | 1994 | 1 |
| 19 | 1993 | 17 | |
| 20 | Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines. | 1991 | 49 |
About Roy Garcia
Roy Garcia is a scholar working on Oncology, Pathology and Forensic Medicine, Toxicology, Pharmacology and Molecular Biology, having authored 28 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (16 papers), Cancer Mechanisms and Therapy (8 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Protein Tyrosine Phosphatases (3 papers), Bluetooth and Wireless Communication Technologies (2 papers), Teleoperation and Haptic Systems (2 papers), Medicinal Plant Pharmacodynamics Research (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Oncology (3.3k citations), Pathology and Forensic Medicine (988 citations), Cancer Research (780 citations), Immunology (1.1k citations) and Toxicology (172 citations). Roy Garcia has collaborated with scholars based in United States, Spain and Portugal. Frequent co-authors include Richard Jove, Tammy Bowman, James Turkson, Rolf P. de Groot, Eric Caldenhoven, Carlos Muro‐Cacho, Robert E. Falcone, Hua Yu, Alan J. Kraker and Sarah J. Parsons. Their work appears in journals such as Oncogene, Journal of Biomedical Science, European Journal of Clinical Microbiology & Infectious Diseases, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.